Does olfactory dysfunction correlate with disease progression in Parkinson's disease? A systematic review of the current literature

T Ercoli, C Masala, G Cadeddu, MM Mascia, G Orofino… - Brain Sciences, 2022 - mdpi.com
Background. Loss of olfaction is a well-established early feature of Parkinson's disease
(PD). Although olfactory dysfunction has been widely described as a prodromal feature of …

[HTML][HTML] Grey matter volume loss in Parkinson's Disease Psychosis and its relationship with serotonergic gene expression: A meta-analysis

S Pisani, B Gunasekera, Y Lu, M Vignando… - Neuroscience & …, 2023 - Elsevier
Background Neuroanatomical alterations underlying psychosis in Parkinson's Disease
(PDP) remain unclear. We carried out a meta-analysis of MRI studies investigating the …

Qualitative smell/taste disorders as sequelae of acute COVID-19

T Ercoli, C Masala, I Pinna, G Orofino, P Solla… - Neurological …, 2021 - Springer
Background Qualitative smell/taste disorders (such as phantosmia, parosmia, phantogeusia,
and parageusia) have not yet been fully characterized in patients who had COVID-19 …

Non-visual hallucinations in Parkinson's disease: a systematic review

WL Toh, C Yolland, C Gurvich, J Barnes… - Journal of Neurology, 2023 - Springer
Background Non-visual hallucinations in Parkinson's disease (PD) can be prevalent and
distressing. Most existing research has however, focused on visual hallucinations as well as …

Dysregulation of human somatic piRNA expression in Parkinson's disease subtypes and stages

T Zhang, G Wong - International Journal of Molecular Sciences, 2022 - mdpi.com
Piwi interacting RNAs (piRNAs) are small non-coding single-stranded RNA species 20–31
nucleotides in size generated from distinct loci. In germline tissues, piRNAs are amplified via …

Serum uric acid levels in Parkinson's disease: a cross-sectional electronic medical record database study from a tertiary referral Centre in Romania

A Dănău, L Dumitrescu, A Lefter, BO Popescu - Medicina, 2022 - mdpi.com
Abstract Background and Objectives: Parkinson's disease (PD) is a prevalent
neurodegenerative condition responsible for progressive motor and non-motor symptoms …

Association between β2-adrenoreceptor medications and risk of Parkinson's disease: A meta-analysis

CL Chen, SY Wang, TC Chen, CS Chuang - Medicina, 2021 - mdpi.com
Background and Objective: Parkinson's disease (PD) is a progressive neurological disorder
characterized by an accumulation of Lewy bodies and degeneration of dopaminergic …

Structural and functional correlates of hallucinations and illusions in Parkinson's disease

A Marques, NL Taylor, D Roquet… - Journal of …, 2022 - content.iospress.com
Background: Visual illusions (VI) in Parkinson's disease (PD) are generally considered as
an early feature of the psychosis spectrum leading to fully formed visual hallucinations (VH) …

Non-contact hand movement analysis for optimal configuration of smart sensors to capture Parkinson's disease hand tremor

P Khwaounjoo, G Singh, S Grenfell, B Özsoy… - Sensors, 2022 - mdpi.com
Parkinson's disease affects millions worldwide with a large rise in expected burden over the
coming decades. More easily accessible tools and techniques to diagnose and monitor …

Phantosmia in Parkinson's Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations

T Ercoli, CF Bagella, C Frau, E Ruiu, S Othmani… - Neurology …, 2023 - mdpi.com
Olfactory dysfunction is a prevalent non-motor symptom in Parkinson's disease (PD),
affecting approximately 65–90% of subjects. PD patients may also report odor perception in …